NMTC - NeuroOne Medical Technologies Corporation
NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 22.65M |
| Enterprise Value | 18.30M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 91.95 |
| Price/Book (mrq) | 2.86 |
| Enterprise Value/Revenue | 26.85 |
| Enterprise Value/EBITDA | -1.98 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.68 |
| 52-Week Change 3 | 11.40% |
| S&P500 52-Week Change 3 | 1.77% |
| 52 Week High 3 | 2.9500 |
| 52 Week Low 3 | 0.7800 |
| 50-Day Moving Average 3 | 1.4863 |
| 200-Day Moving Average 3 | 1.5707 |
Share Statistics
| Avg Vol (3 month) 3 | 228.42k |
| Avg Vol (10 day) 3 | 153.07k |
| Shares Outstanding 5 | 17.56M |
| Implied Shares Outstanding 6 | N/A |
| Float 8 | 14.92M |
| % Held by Insiders 1 | 17.59% |
| % Held by Institutions 1 | 8.08% |
| Shares Short (May 14, 2023) 4 | 111.65k |
| Short Ratio (May 14, 2023) 4 | 0.62 |
| Short % of Float (May 14, 2023) 4 | 0.67% |
| Short % of Shares Outstanding (May 14, 2023) 4 | 0.64% |
| Shares Short (prior month Apr 13, 2023) 4 | 395.92k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:3 |
| Last Split Date 3 | Mar 31, 2021 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Sept 29, 2022 |
| Most Recent Quarter (mrq) | Mar 30, 2023 |
Profitability
| Profit Margin | -230.18% |
| Operating Margin (ttm) | -231.46% |
Management Effectiveness
| Return on Assets (ttm) | -55.43% |
| Return on Equity (ttm) | -100.66% |
Income Statement
| Revenue (ttm) | 4.08M |
| Revenue Per Share (ttm) | 0.25 |
| Quarterly Revenue Growth (yoy) | 1,174.30% |
| Gross Profit (ttm) | -3.05M |
| EBITDA | -9.3M |
| Net Income Avi to Common (ttm) | -9.39M |
| Diluted EPS (ttm) | -0.6000 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 4.6M |
| Total Cash Per Share (mrq) | 0.26 |
| Total Debt (mrq) | 243.98k |
| Total Debt/Equity (mrq) | 4.41 |
| Current Ratio (mrq) | 4.10 |
| Book Value Per Share (mrq) | 0.33 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -8.66M |
| Levered Free Cash Flow (ttm) | -5.48M |
© 2023 Yahoo. All rights reserved.